Bumrungrad Hospital Public Company Limited (BZ7A.F)
Bumrungrad Hospital Public Company Limited operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bangkok, BM, TH. The stock last traded at $4.84, down 0.41% on the session, giving a market capitalisation of $3.85B. Its beta of 0.18 implies it has historically moved less than the broad market.
Bumrungrad Hospital Public Company Limited is a prominent global healthcare provider, managing and operating medical facilities both within Thailand and across international borders. Its core medical centers deliver comprehensive services, including diagnostic testing, various therapeutic treatments, and critical intensive care. The company maintains an extensive network of approximately 56 specialized outpatient clinics and centers, catering to a vast array of medical needs. These include, but are not limited to, cardiology, oncology, orthopedics, neurology, pediatrics, women's health, dentistry, physical therapy, and emergency services, alongside highly specialized offerings such as IVF, hyperbaric oxygen therapy, and advanced surgical procedures like robotic surgery. Beyond direct patient care, Bumrungrad is also involved in managing real estate assets, conducting clinical research, distributing pharmaceuticals and medical supplies through dedicated retail outlets, operating a personnel development and training center for healthcare services, and providing patient referral services. Established in 1980 and headquartered in Bangkok, Thailand, the company operates with a capacity of 580 beds.
Bumrungrad Hospital Public Company Limited is most often compared with the following Healthcare names: